The Effects of Various Cooking Oils on Health Related Biomarkers in Healthy Subjects
NCT ID: NCT02599103
Last Updated: 2015-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2013-09-30
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Palm Olein Intake on Lipid Profile and Fat Deposition
NCT02897674
Different Oils For Frying and Endothelial Function
NCT00837317
Inflammation, Polyphenols, and Genetics
NCT01568827
Study of Acute Effects of Sn-1 and Sn-3 Palmitic Acid-rich or Stearic Acid-rich Fats on Metabolic Markers
NCT01428960
Establishing Reference Ranges for Fat-Soluble Vitamins in Healthy Chinese Adults
NCT06512688
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fat-free milkshake
Fat-free milkshake
participants drinks a fat-free milk shakes
Olive oil
Olive oil
participants drinks the milk shakes prepared from 60g of olive oil
soybean oil
Soybean oil
participants drinks the milk shakes prepared from 60g of soybean oil
fried soybean oil
Fried soybean oil
participants drinks the milk shakes prepared from 60g of fried soybean oil
palm oil
Palm oil
participants drinks the milk shakes prepared from 60g of palm oil
fried palm oil
Fried palm oil
participants drinks the milk shakes prepared from 60g of fried palm oil
camellia oil
Camellia oil
participants drinks the milk shakes prepared from 60g of camellia oil
fried camellia oil
Fried camellia oil
participants drinks the milk shakes prepared from 60g of fried camellia oil
tallow
Tallow
participants drinks the milk shakes prepared from 60g of tallow
fried tallow
Fried tallow
participants drinks the milk shakes prepared from 60g of fried tallow
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fat-free milkshake
participants drinks a fat-free milk shakes
Olive oil
participants drinks the milk shakes prepared from 60g of olive oil
Soybean oil
participants drinks the milk shakes prepared from 60g of soybean oil
Fried soybean oil
participants drinks the milk shakes prepared from 60g of fried soybean oil
Palm oil
participants drinks the milk shakes prepared from 60g of palm oil
Fried palm oil
participants drinks the milk shakes prepared from 60g of fried palm oil
Camellia oil
participants drinks the milk shakes prepared from 60g of camellia oil
Fried camellia oil
participants drinks the milk shakes prepared from 60g of fried camellia oil
Tallow
participants drinks the milk shakes prepared from 60g of tallow
Fried tallow
participants drinks the milk shakes prepared from 60g of fried tallow
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI : 18.5\~27 kg/m2
Exclusion Criteria
2. None of the subjects was taking any supplemental vitamins, antioxidants or medication at that time.
3. Taking steroids or non-steroidal anti-inflammatory drug, such as Aspirin or Panadol in the past one week.
4. Cancer or other severe diseases was diagnosed.
20 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Academia Sinica, Taiwan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wen-Harn Pan
Institute of Biomedical Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wen-Harn Pan, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Institute of Biomedical Sciences, Academia Sinica
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AS-IRB02-102083
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.